Ignite Creation Date:
2024-05-06 @ 11:22 AM
Last Modification Date:
2024-10-26 @ 12:44 PM
Study NCT ID:
NCT03505008
Status:
UNKNOWN
Last Update Posted:
2021-09-01
First Post:
2018-04-16
Brief Title:
Evaluation of the Optimal MTX Dose as an Add-on Therapy to Adalimumab for RA Patients in Japan South Korea and Taiwan
Sponsor:
Organization:
Keio University